Verdiperstat attenuates acute lung injury by modulating MPO/μ-calpain/β-catenin signaling.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of pharmacology"
DOI: 10.1016/j.ejphar.2022.174940
Abstract: Verdiperstat, a myeloperoxidase (MPO) inhibitor, is a well-known drug used for the treatment of multisystem atrophy. However, its therapeutic effect on acute lung injury (ALI) remains to be elucidated. In this study, the effect of… read more here.
Keywords: catenin; acute lung; verdiperstat; injury ... See more keywords